Orion slips as Q1 falls short of expectations

Orion Oyj

23/04/2026 11:29

** Shares in Finnish pharmaceutical company Orion ORNBV.HE fall nearly 6% after its Q1 report with sales and earnings a tad lower than expected

** It reported Q1 sales of EUR 417.7 million ($488.46 million) against Vara Research estimate of EUR 426.1 million

** Sales lag consensus, largely driven by miss on Nubeqa, as well as more modestly by Generics and Animal Health, Jefferies says

** While Nubeqa sales came in-line with Jefferies expectations, royalties were 5% below

** The brokerage notes Orion lifted the low ends of net sales and operating profit forecasts, but added the upgrades were as expected

** The shares erase their April gains, and are on track for their worst day since February, if losses hold

($1 = 0.8551 euros)

 (Reporting by Elviira Luoma)

 ((Elviira.luoma@thomsonreuters.com))